Skip to content
Opticyte
The World’s Only Cell O₂ Monitor
Toggle Mobile Navigation Menu
Technology
About Us
Investors
COVID-19
News
Contact Us
News
Opticyte Earns FDA Breakthrough Device Designation for the First Cell O
2
Patient Monitor for Organ Failure
Posted on
January 9, 2023
Last Updated: February 25, 2023
Read Story
News
Filter by
All
Filter By
All
News
Opticyte Earns FDA Breakthrough Device Designation for the First Cell O
2
Patient Monitor for Organ Failure
Posted on
January 9, 2023
Last Updated: February 25, 2023
News
CEO Lori Arakaki on Working with StarFish Medical
Posted on
November 16, 2022
Last Updated: February 25, 2023
News
Pacific Northwest Sepsis Conference
Posted on
April 29, 2021
Last Updated: February 25, 2023
News
CEO Lori Arakaki on Creating Successful Academic Spin-outs
Posted on
February 17, 2021
Last Updated: February 25, 2023
News
GeekWire: UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure
Lisa Stiffler, GeekWire
Posted on
January 13, 2021
Last Updated: February 25, 2023
News
Opticyte Secures $4.6 Million in Funding to Develop First Cell O2 Monitor for Reducing Organ Failure
Posted on
January 13, 2021
Last Updated: February 25, 2023
News
Opticyte: Why the Need is Now
Lori Arakaki, CEO & Co-founder
Posted on
December 11, 2020
Last Updated: January 13, 2021
Join the Opticyte Solution
Learn How
Home
Technology
About Us
Investors
News
Contact Us